COMPANY

Roche

Roche is a pharmaceuticals, diagnostics and digital health software for healthcare.

Analyst Perspective

Roche is a Swiss multinational healthcare company that develops, manufactures and sells pharmaceuticals, diagnostics and related digital health solutions. Its core business is organised around Pharmaceuticals and Diagnostics, with the navify portfolio extending the Diagnostics division into enterprise software for hospitals, laboratories and healthcare systems. The company operates globally and reports group-level results at scale. Roche generates revenue primarily from prescription medicines, diagnostic instruments, tests, reagents and associated healthcare software. Its software products are sold to enterprise healthcare customers through subscriptions, licences, bundled solutions and service agreements, while patient-facing digital properties support clinical trial awareness and engagement rather than serving as the primary revenue engine.

Analyst Signal Briefing

Updated: 28 Jul 2026

Roche has successfully transitioned into a post-pandemic growth phase, reporting 7% base business growth driven by franchises such as Vabysmo and Ocrevus. The group is prioritising expansion into the obesity and metabolic disease markets whilst integrating AI-driven diagnostics into its core strategy. Complementing these clinical pivots, Roche has accelerated its internal digitisation by deploying over 90,000 Microsoft 365 Copilot seats, positioning the company as a leading enterprise adopter of generative AI tools to enhance productivity and engagement across its global operations.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

Roche is a global healthcare manufacturer and diagnostics company, not an adtech, martech or media platform. Its navify products are clinical and laboratory software tools, not advertising analytics products.

Roche: About

Roche runs a diversified healthcare model combining biopharma R&D, diagnostics manufacturing and enterprise healthcare software. It creates value by discovering and commercialising medicines, selling diagnostic platforms and consumables into clinical settings, and embedding software such as navify into laboratory and care workflows to improve operational performance and strengthen customer retention across the diagnostics ecosystem.

How Roche Works & Monetises

Business model analysis and core revenue streams

Roche monetises through a mix of pharmaceutical product sales, diagnostic instrument placements, recurring consumables and enterprise software revenue. Digital products such as navify are commercialised as SaaS platforms, software licences, bundled workflow solutions and long-term service agreements tied to diagnostics infrastructure. This creates recurring revenue through reagent pull-through, maintenance, software subscriptions and enterprise account expansion.

Revenue Channels

Pharmaceutical product salesOne-time Sale
Diagnostic instruments, tests and reagentsOne-time Sale
Enterprise healthcare software subscriptionsSoftware Subscription
Service, support and workflow agreementsService Fee

Side-by-Side Comparisons

Compare Roche directly with top competitors

Products & Services in Categories

Verified structural categorizations from the graph

Roche: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (Roche)

Investor RelationsJul 23, 2026

Investor Presentation Released: Roche

AI parsed presentation narrative: Roche is successfully transitioning to a post-pandemic growth phase, with base business growth of 7% and core operating profit expanding faster than sales. The strategy focuses on maximizing high-growth franchises like Vabysmo and Ocrevus while aggressively expanding into the obesity market and AI-driven diagnostics. Strategic pillars: Maximizing value of existing growth drivers, Leading in Obesity and Metabolic disease.

Read original source
persoenlich.com NewsJul 2, 2026

Katrin Nesemann Joins Boldt BPI as Partner in Zurich

Katrin Nesemann, a transformation specialist, will become a partner at Boldt BPI's Zurich office effective July 2026. She will work with founding partner Matthias Graf to expand Boldt BPI's business in the DACH region. Nesemann previously joined the partner circle at the German‑Swiss consultancy CCounselors in January 2025 and has held senior roles including Managing Partner at the Witten Group, Head of Internal Communications at Bank Vontobel, and international public‑policy responsibilities at Roche. The appointment coincides with continued European expansion of the BPI Group (which Boldt BPI joined at the end of 2023); the group added Berlin agency 365 Sherpas (~60 employees) in spring 2026 and reports over 400 employees across eleven locations in the US and Europe.

Read original source
persoenlich.com NewsJun 23, 2026

Adveritas Joins Leading Swiss Agencies

Adveritas, a 12-person, owner-managed full-service agency based in Belp, has joined the industry association Leading Swiss Agencies (LSA) effective immediately. The agency specialises in cross-media communication and performance marketing, offering services including print and digital media planning, programmatic advertising, out-of-home (OOH), and bespoke web development. Adveritas is a certified Google Partner and serves clients such as Roche, Fenaco, Fust Küchen & Bäder and the KMU-Institut of the University of St. Gallen. The firm uses a customised software solution for print media planning and augments its core team with a network of freelancers and external media advisors.

Read original source

Roche: Frequently Asked Questions

What is Roche?

Roche is a Swiss healthcare company that develops pharmaceuticals, diagnostics and enterprise digital health software for clinical and laboratory settings.

Who uses Roche?

Roche is used by hospitals, clinical laboratories, health systems, pathologists, healthcare professionals and procurement teams; patients mainly use its clinical trial information platform.

How does Roche make money?

Roche makes money from selling medicines, diagnostic instruments, tests, reagents and enterprise software subscriptions, licences and service agreements.

Company Facts

Founded
1896
Headquarters
Grenzacherstrasse 124, 4058 Basel
Core Segment
Other / Non-Digital Advertising Relevant
Company Size
>5,000
Official Link
roche.com